Rectal Cancer Archives - Page 4 of 6 - Cancer Therapy Advisor

For postmenopausal women with ductal carcinoma in situ, anastrozole is more effective than tamoxifen

Gastrointestinal Cancers

Capecitabine Established as Standard of Care in Pre-Op Rectal Cancer Setting

By

Jason Hoffman, PharmD, RPh

October 21, 2015

Capecitabine should be considered a standard of care in the pre-operative rectal cancer setting.

Tumor histology may be an important predictor of how successful treatment with radio frequency ablat

Gastrointestinal Cancers

Local Excision After CRT May Be Organ-Preserving Alternative for Rectal Cancer

By

Jason Hoffman, PharmD, RPh

October 15, 2015

Neoadjuvant chemoradiotherapy followed by local excision may be an organ-preserving alternative in certain patients with clinical T2N0 rectal cancer.

Two studies found that laparoscopic surgery for rectal cancer found that it was potentially inferior

Gastrointestinal Cancers

Laparoscopic vs Open Surgery for Rectal Cancer

By

Carlos Harrison

October 13, 2015

Two studies found that laparoscopic surgery for rectal cancer found that it was potentially inferior to open-surgery.

Aspirin might have anticancer activity against rectal cancer during preoperative chemoradiation.

Gastrointestinal Cancers

Adding Aspirin to Preoperative CRT May Be Beneficial for Rectal Cancer

By

Jason Hoffman, PharmD, RPh

September 23, 2015

Aspirin might have anticancer activity against rectal cancer during preoperative chemoradiation.

Acute toxicity rate is high in elderly head and neck squamous cell carcinoma patients undergoing che

Gastrointestinal Cancers

Elderly Patients with Rectal Cancer May Face Similar Survival Outcomes as Younger Patients

By

Stephen Cho

July 31, 2015

Older patients seem to face similar outcomes as younger patients when treated with neoadjuvant chemoradiation for rectal cancer.

Addition of sorafenib to standard chemotherapy for the treatment of younger patients with AML is eff

Gastrointestinal Cancers

Oxaliplatin Added to Standard of Care Therapy Increased Disease-Free Survival for Rectal Cancer

By

Lourdes Briz

July 17, 2015

Standard combined modality treatment for locally advanced rectal cancer had less disease-free survival than a new CRO/ARO/AIO-04 regimen.

Compared with prednisone, cabozantinib does not improve overall survival rates for men with mCRPC.

Gastrointestinal Cancers

Statin Use Linked with Lower Mortality after Colorectal Cancer Diagnosis

By

Jason Hoffman, PharmD, RPh

July 17, 2015

Cumulative exposure to statins after a diagnosis of colorectal cancer was associated with lower overall mortality.

The top inherited genetic loci are likely linked with the development of asparaginase hypersensitivi

Gastrointestinal Cancers

Possible Link Between rs61764370, Prognosis in Colorectal Cancer

July 15, 2015

Single nucleotide polymorphism in the let-7 complementary site 6 of KRAS mRNA may be a response biomarker in colorectal cancer.

Colon cancer: Adding cetuximab to chemotherapy

Gastrointestinal Cancers

Colorectal Cancer Death “Hotspots” Indicate Need for Increased Screening in Some Areas

By

Lourdes Briz

July 13, 2015

Investigators recommend prioritized screening in certain pockets of the U.S. that are statistically identified as colorectal cancer (CRC) death hotspots.

Combating Colon Cancer Based on Genetic Mutations

Gastrointestinal Cancers

US State Disparities in Colorectal Cancer Rates

July 10, 2015

Greater progress in reducing colorectal cancer incidence, mortality rates observed in Northeastern states compared to Southern states.